US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 31.510
  • -0.850-2.63%
Close Jun 14 16:00 ET
  • 31.280
  • -0.230-0.73%
Post 16:23 ET
1.60BMarket Cap-693P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-61.86%-28.54M
-24.66%-99.91M
-71.09%-31.04M
-129.61%-34.6M
19.49%-16.64M
32.86%-17.63M
-49.20%-80.14M
5.85%-18.14M
11.36%-15.07M
-1,092.94%-20.67M
Net income from continuing operations
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
Operating gains losses
----
--214.63M
--0
--25.06M
----
----
----
----
----
217.75%272K
Depreciation and amortization
--0
-52.52%744K
-336.56%-220K
--0
-26.89%416K
35.98%548K
-0.57%1.57M
-77.37%93K
21.84%502K
42.96%569K
Other non cash items
21,400.00%430K
236.82%2.77M
3,854.03%18.66M
-4,540.50%-15.9M
103.88%4K
-97.92%2K
814.44%823K
291.87%472K
216.81%358K
-189.57%-103K
Change In working capital
354.62%3.47M
5.40%-5.21M
-60.88%-1.86M
-803.01%-7.95M
659.70%5.97M
69.06%-1.36M
-400.22%-5.5M
23.46%-1.16M
128.48%1.13M
-116.70%-1.07M
-Change in receivables
--0
-14.77%375K
-44.56%163K
880.53%1.48M
-346.90%-1.32M
122.84%45K
153.99%440K
136.07%294K
---190K
-97.52%533K
-Change in prepaid assets
-161.25%-381K
383.65%3.25M
-103.78%-65K
86.94%-58K
206.89%2.75M
314.67%622K
5.92%-1.14M
407.08%1.72M
-133.61%-444K
-1.30%-2.57M
-Change in payables and accrued expense
316.52%3.85M
-103.07%-7.08M
35.70%-1.96M
-509.36%-7.35M
221.89%4.01M
48.79%-1.78M
-603.47%-3.48M
-259.69%-3.05M
154.97%1.8M
8.06%1.25M
-Change in other current liabilities
--0
-434.71%-2.33M
--0
-4,214.89%-2.03M
23.66%-100K
-66.39%-198K
-7.67%-435K
-16.95%-138K
64.12%-47K
-309.38%-131K
-Change in other working capital
----
165.34%575K
--0
--0
527.21%628K
93.09%-53K
-124.61%-880K
100.60%17K
101.22%17K
98.93%-147K
Cash from discontinued investing activities
Operating cash flow
-61.86%-28.54M
-24.66%-99.91M
-71.09%-31.04M
-129.61%-34.6M
19.49%-16.64M
32.86%-17.63M
-49.20%-80.14M
5.85%-18.14M
11.36%-15.07M
-1,092.94%-20.67M
Investing cash flow
Cash flow from continuing investing activities
-691.34%-104.96M
-290.14%-108.39M
-351.94%-35.27M
-691.74%-97.63M
801.33%6.76M
-31.09%17.75M
352.04%57.01M
44.88%14M
185.60%16.5M
101.58%750K
Net PPE purchase and sale
----
1,350.00%475K
--0
--0
----
----
93.37%-38K
--0
98.92%-1K
--0
Net intangibles purchase and sale
----
--15M
--0
----
----
----
--0
--0
----
----
Net business purchase and sale
----
--3.04M
--0
--0
----
----
--0
--0
--0
----
Net investment purchase and sale
-691.34%-104.96M
-322.46%-126.9M
-351.94%-35.27M
-782.61%-112.63M
333.33%3.25M
-31.19%17.75M
358.76%57.05M
44.88%14M
181.09%16.5M
101.58%750K
Cash from discontinued investing activities
Investing cash flow
-691.34%-104.96M
-290.14%-108.39M
-351.94%-35.27M
-691.74%-97.63M
801.33%6.76M
-31.09%17.75M
352.04%57.01M
44.88%14M
185.60%16.5M
101.58%750K
Financing cash flow
Cash flow from continuing financing activities
1,721,550.00%172.17M
746.05%361.08M
2,045,175.00%163.61M
-9,539.23%-12.53M
390.59%209.99M
-16.67%10K
2,963.75%42.68M
-110.00%-8K
-111.37%-130K
22,393.75%42.8M
Net issuance payments of debt
--0
96.17%-16K
--0
--0
95.43%-8K
95.35%-8K
18.04%-418K
95.27%-8K
41.67%-63K
23.25%-175K
Net common stock issuance
----
294.43%169.11M
--169.11M
--0
----
----
--42.87M
--0
---105K
----
Net preferred stock issuance
--169.21M
--197.36M
--0
---12.64M
--210M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
24,288.89%4.39M
82.43%405K
--282K
176.32%105K
--0
-90.22%18K
-88.33%222K
--0
-96.96%38K
--0
Net other financing activities
---1.43M
---5.79M
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,721,550.00%172.17M
746.05%361.08M
2,045,175.00%163.61M
-9,539.23%-12.53M
390.59%209.99M
-16.67%10K
2,963.75%42.68M
-110.00%-8K
-111.37%-130K
22,393.75%42.8M
Net cash flow
Beginning cash position
419.59%189.22M
114.46%36.42M
126.81%91.9M
502.63%236.68M
122.00%36.55M
114.46%36.42M
-81.53%16.98M
52.89%40.52M
7.27%39.27M
-79.94%16.47M
Current changes in cash
30,582.54%38.66M
681.77%152.77M
2,445.66%97.3M
-11,226.75%-144.76M
774.56%200.11M
125.61%126K
126.08%19.54M
56.45%-4.15M
112.91%1.3M
150.32%22.88M
Effect of exchange rate changes
-136.36%-4K
123.58%25K
-60.87%18K
70.18%-17K
118.06%13K
147.83%11K
-606.67%-106K
1,433.33%46K
-96.55%-57K
-1,900.00%-72K
End cash Position
523.40%227.87M
419.59%189.22M
419.59%189.22M
126.81%91.9M
502.63%236.68M
122.00%36.55M
114.46%36.42M
114.46%36.42M
52.89%40.52M
7.27%39.27M
Free cash flow
-61.86%-28.54M
-24.60%-99.91M
-71.09%-31.04M
-129.59%-34.6M
19.49%-16.64M
32.95%-17.63M
-47.69%-80.18M
5.85%-18.14M
11.84%-15.07M
-1,107.46%-20.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -61.86%-28.54M-24.66%-99.91M-71.09%-31.04M-129.61%-34.6M19.49%-16.64M32.86%-17.63M-49.20%-80.14M5.85%-18.14M11.36%-15.07M-1,092.94%-20.67M
Net income from continuing operations -138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M10.21%-18.23M-226.84%-22.32M
Operating gains losses ------214.63M--0--25.06M--------------------217.75%272K
Depreciation and amortization --0-52.52%744K-336.56%-220K--0-26.89%416K35.98%548K-0.57%1.57M-77.37%93K21.84%502K42.96%569K
Other non cash items 21,400.00%430K236.82%2.77M3,854.03%18.66M-4,540.50%-15.9M103.88%4K-97.92%2K814.44%823K291.87%472K216.81%358K-189.57%-103K
Change In working capital 354.62%3.47M5.40%-5.21M-60.88%-1.86M-803.01%-7.95M659.70%5.97M69.06%-1.36M-400.22%-5.5M23.46%-1.16M128.48%1.13M-116.70%-1.07M
-Change in receivables --0-14.77%375K-44.56%163K880.53%1.48M-346.90%-1.32M122.84%45K153.99%440K136.07%294K---190K-97.52%533K
-Change in prepaid assets -161.25%-381K383.65%3.25M-103.78%-65K86.94%-58K206.89%2.75M314.67%622K5.92%-1.14M407.08%1.72M-133.61%-444K-1.30%-2.57M
-Change in payables and accrued expense 316.52%3.85M-103.07%-7.08M35.70%-1.96M-509.36%-7.35M221.89%4.01M48.79%-1.78M-603.47%-3.48M-259.69%-3.05M154.97%1.8M8.06%1.25M
-Change in other current liabilities --0-434.71%-2.33M--0-4,214.89%-2.03M23.66%-100K-66.39%-198K-7.67%-435K-16.95%-138K64.12%-47K-309.38%-131K
-Change in other working capital ----165.34%575K--0--0527.21%628K93.09%-53K-124.61%-880K100.60%17K101.22%17K98.93%-147K
Cash from discontinued investing activities
Operating cash flow -61.86%-28.54M-24.66%-99.91M-71.09%-31.04M-129.61%-34.6M19.49%-16.64M32.86%-17.63M-49.20%-80.14M5.85%-18.14M11.36%-15.07M-1,092.94%-20.67M
Investing cash flow
Cash flow from continuing investing activities -691.34%-104.96M-290.14%-108.39M-351.94%-35.27M-691.74%-97.63M801.33%6.76M-31.09%17.75M352.04%57.01M44.88%14M185.60%16.5M101.58%750K
Net PPE purchase and sale ----1,350.00%475K--0--0--------93.37%-38K--098.92%-1K--0
Net intangibles purchase and sale ------15M--0--------------0--0--------
Net business purchase and sale ------3.04M--0--0----------0--0--0----
Net investment purchase and sale -691.34%-104.96M-322.46%-126.9M-351.94%-35.27M-782.61%-112.63M333.33%3.25M-31.19%17.75M358.76%57.05M44.88%14M181.09%16.5M101.58%750K
Cash from discontinued investing activities
Investing cash flow -691.34%-104.96M-290.14%-108.39M-351.94%-35.27M-691.74%-97.63M801.33%6.76M-31.09%17.75M352.04%57.01M44.88%14M185.60%16.5M101.58%750K
Financing cash flow
Cash flow from continuing financing activities 1,721,550.00%172.17M746.05%361.08M2,045,175.00%163.61M-9,539.23%-12.53M390.59%209.99M-16.67%10K2,963.75%42.68M-110.00%-8K-111.37%-130K22,393.75%42.8M
Net issuance payments of debt --096.17%-16K--0--095.43%-8K95.35%-8K18.04%-418K95.27%-8K41.67%-63K23.25%-175K
Net common stock issuance ----294.43%169.11M--169.11M--0----------42.87M--0---105K----
Net preferred stock issuance --169.21M--197.36M--0---12.64M--210M--0--0--0--0----
Proceeds from stock option exercised by employees 24,288.89%4.39M82.43%405K--282K176.32%105K--0-90.22%18K-88.33%222K--0-96.96%38K--0
Net other financing activities ---1.43M---5.79M--------------------------------
Cash from discontinued financing activities
Financing cash flow 1,721,550.00%172.17M746.05%361.08M2,045,175.00%163.61M-9,539.23%-12.53M390.59%209.99M-16.67%10K2,963.75%42.68M-110.00%-8K-111.37%-130K22,393.75%42.8M
Net cash flow
Beginning cash position 419.59%189.22M114.46%36.42M126.81%91.9M502.63%236.68M122.00%36.55M114.46%36.42M-81.53%16.98M52.89%40.52M7.27%39.27M-79.94%16.47M
Current changes in cash 30,582.54%38.66M681.77%152.77M2,445.66%97.3M-11,226.75%-144.76M774.56%200.11M125.61%126K126.08%19.54M56.45%-4.15M112.91%1.3M150.32%22.88M
Effect of exchange rate changes -136.36%-4K123.58%25K-60.87%18K70.18%-17K118.06%13K147.83%11K-606.67%-106K1,433.33%46K-96.55%-57K-1,900.00%-72K
End cash Position 523.40%227.87M419.59%189.22M419.59%189.22M126.81%91.9M502.63%236.68M122.00%36.55M114.46%36.42M114.46%36.42M52.89%40.52M7.27%39.27M
Free cash flow -61.86%-28.54M-24.60%-99.91M-71.09%-31.04M-129.59%-34.6M19.49%-16.64M32.95%-17.63M-47.69%-80.18M5.85%-18.14M11.84%-15.07M-1,107.46%-20.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg